BioCentury
ARTICLE | Company News

Phenomix, Forest Laboratories deal

October 27, 2008 7:00 AM UTC

The partners will co-develop and commercialize Phenomix's dutogliptin (formerly PHX1149) to treat Type II diabetes in North America. The dipeptidyl peptidase-4 (DPP-4) inhibitor is in Phase III testi...